[1] |
Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update[J]. Allergy, 2014,69(7):868⁃887. doi: 10.1111/all.12313.
|
[2] |
Kolkhir P, Church MK, Weller K, et al. Autoimmune chronic spontaneous urticaria: what we know and what we do not know[J]. J Allergy Clin Immunol, 2017,139(6):1772⁃1781.e1. doi: 10.1016/j.jaci.2016.08.050.
|
[3] |
Chen L, Heikkinen L, Wang C, et al. Trends in the development of miRNA bioinformatics tools[J]. Brief Bioinform, 2019,20(5):1836⁃1852. doi: 10.1093/bib/bby054.
|
[4] |
叶瑞贤, 薛如君, 梁景耀, 等. microRNA在炎症性皮肤病中作用的研究进展[J]. 中华皮肤科杂志, 2021,54(2):178⁃182. doi: 10.35541/cjd.20190864.
|
[5] |
Latini A, Ciccacci C, Novelli G, et al. Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility[J]. Immunol Res, 2017,65(4):811⁃827. doi: 10. 1007/s12026⁃017⁃8937⁃8.
|
[6] |
中华医学会皮肤性病学分会荨麻疹研究中心. 中国荨麻疹诊疗指南(2018版)[J]. 中华皮肤科杂志, 2019,52(1):1⁃5. doi: 10.3760/cma.j.issn.0412⁃4030.2019.01.001.
|
[7] |
Brzoza Z, Grzeszczak W, Rogala B, et al. PTPN22 polymorphism presumably plays a role in the genetic background of chronic spontaneous autoreactive urticaria[J]. Dermatology, 2012,224(4):340⁃345. doi: 10.1159/000339332.
|
[8] |
Brzoza Z, Grzeszczak W, Rogala B, et al. Possible contribution of chemokine receptor CCR2 and CCR5 polymorphisms in the pathogenesis of chronic spontaneous autoreactive urticaria[J]. Allergol Immunopathol (Madr), 2014,42(4):302⁃306. doi: 10. 1016/j.aller.2013.02.003.
|
[9] |
Guo A, Zhu W, Zhang C, et al. Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1⁃antihistamines in Chinese patients[J]. Arch Dermatol Res, 2015,307(2):183⁃190. doi: 10.1007/s00403⁃014⁃1525⁃z.
|
[10] |
Brzoza Z, Grzeszczak W, Trautsolt W, et al. Inducible T⁃cell costimulator (ICOS) and CD28 polymorphisms possibly play a role in the pathogenesis of chronic autoreactive urticaria[J]. Clin Exp Dermatol, 2017,42(8):863⁃867. doi: 10.1111/ced. 13212.
|
[11] |
Movahedi M, Tavakol M, Rahmani F, et al. Single nucleotide polymorphisms of IL⁃2, but not IL⁃12 and IFN⁃γ, are associated with increased susceptibility to chronic spontaneous urticaria[J]. Allergol Immunopathol (Madr), 2017,45(4):333⁃338. doi: 10.1016/j.aller.2016.10.009.
|
[12] |
Li J, Guo A, Chen W, et al. Association of ORAI1 gene polymorphisms with chronic spontaneous urticaria and the efficacy of the nonsedating H1 antihistamine desloratadine[J]. J Allergy Clin Immunol, 2017,139(4):1386⁃1388.e9. doi: 10.1016/ j.jaci.2016.10.017.
|
[13] |
Hoffman AE, Zheng T, Yi C, et al. microRNA miR⁃196a⁃2 and breast cancer: a genetic and epigenetic association study and functional analysis[J]. Cancer Res, 2009,69(14):5970⁃5977. doi: 10.1158/0008⁃5472.CAN⁃09⁃0236.
|
[14] |
Qi J, Hou S, Zhang Q, et al. A functional variant of pre⁃miRNA⁃196a2 confers risk for Behcet′s disease but not for Vogt⁃Koyanagi⁃Harada syndrome or AAU in ankylosing spondylitis[J]. Hum Genet, 2013,132(12):1395⁃1404. doi: 10.1007/s00439⁃ 013⁃1346⁃8.
|
[15] |
Gazouli M, Papaconstantinou I, Stamatis K, et al. Association study of genetic variants in miRNAs in patients with inflammatory bowel disease: preliminary results[J]. Dig Dis Sci, 2013,58(8):2324⁃2328. doi: 10.1007/s10620⁃013⁃2640⁃y.
|
[16] |
Yang S, Zheng Y, Zhou L, et al. miR⁃499 rs3746444 and miR⁃196a⁃2 rs11614913 Are Associated with the Risk of Glioma, but Not the Prognosis[J]. Mol Ther Nucleic Acids, 2020,22:340⁃351. doi: 10.1016/j.omtn.2020.08.038.
|